Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Global Quantum Technology Market Research Report 2023: Significant Developments with IBM, Microsoft and Other Technology Leaders

Published

on

<!– Name:DistributionId Value:8839141 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:2790 –> <!– Name:CustomerId Value:1026737 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:8fc583df-a5dc-4986-900c-107ccecbd31e –>

Dublin, May 15, 2023 (GLOBE NEWSWIRE) — The “Quantum Technology Market by Computing, Communications, Imaging, Security, Sensing, Modeling and Simulation 2023 – 2028” report has been added to ResearchAndMarkets.com’s offering.

This report provides a comprehensive analysis of the quantum technology market. It assesses companies/organizations focused on quantum technology including R&D efforts and potential gaming-changing quantum tech-enabled solutions.

The report evaluates the impact of quantum technology upon other major technologies and solution areas including, Edge Computing, Blockchain, IoT, and Big Data Analytics. The report provides an analysis of quantum technology investment, R&D, and prototyping by region and within each major country globally.

The report also provides global and regional forecasts as well as the outlook for quantum technology’s impact on embedded hardware, software, applications, and services from 2023 to 2028. The report provides conclusions and recommendations for a wide range of industries and commercial beneficiaries including semiconductor companies, communications providers, high-speed computing companies, artificial intelligence vendors, and more.

Much more than only computing, the quantum technology market provides a foundation for improving all digital communications, applications, content, and commerce. In the realm of communications, quantum technology will influence everything from encryption to the way that signals are passed from point A to point B. While currently in the R&D phase, networked quantum information and communications technology(ICT) is anticipated to become a commercial reality that will represent nothing less than a revolution for virtually every aspect of ICT.

However, there will be a need to integrate the ICT supply chain with quantum technologies in a manner that does not attempt to replace every aspect of classical computing but instead leverages a hybrid computational framework. Traditional high-performance computing will continue to be used for many existing problems for the foreseeable future, while quantum technologies will be used for encrypting communications, signalling, and will be the underlying basis in the future for all commerce transactions. This does not mean that quantum encryption will replace blockchain, but rather provide improved encryption for blockchain technology.

Quantum Technology Market Beyond Computing

The quantum technology market will be a substantial enabler of dramatically improved sensing and instrumentation. For example, gravity sensors may be made significantly more precise through quantum sensing. Quantum electromagnetic sensing provides the ability to detect minute differences in the electromagnetic field.

This will provide a wide-ranging number of applications, such as within the healthcare arena wherein quantum electromagnetic sensing will provide the ability to provide significantly improved mapping of vital organs. Quantum sensing will also have applications across a wide range of other industries such as transportation wherein there is the potential for substantially improved safety, especially for self-driving vehicles.

Quantum sensing and imaging go hand-in-hand as the former supports the latter and vice versa. Quantum sensing may be used to produce images that reveal information heretofore unobtainable. Conversely, quantum image processing may be used to dramatically improve microscopy, pattern recognition, and segmentation in images. Quantum processes enable detection of image details that would otherwise go unnoticed within the current constraints of background effects/illumination, low light levels, and wavelength limitations.

Commercial applications for the quantum imaging market are potentially wide-ranging including exploration, monitoring, and safety. For example, gas image processing may detect minute changes that could lead to early detection of tank failure or the presence of toxic chemicals. In concert with quantum sensing, quantum imaging may also help with various public safety-related applications such as search and rescue. Some problems are too difficult to calculate but can be simulated and modelled.

Quantum simulations and modelling is an area that involves the use of quantum technology to enable simulators that can model complex systems that are beyond the capabilities of classical. Even the fastest supercomputers today cannot adequately model many problems such as those found in atomic physics, condensed-matter physics, and high-energy physics.

To accomplish this goal, quantum simulators create a more controllable quantum environment to simulate what is actually occurring in nature within a real-world, uncontrollable, inaccessible quantum environment. Quantum simulation and modelling can lead to a variety of practical commercial benefits such as the design of improved computing systems, development of new materials, and predictive analytics for large interdependent systems such as a smart city ecosystem.

Sovereign governments are extremely interested in the quantum technology market and the interest goes way beyond the pride of being the first to be able to claim quantum supremacy for developing a quantum computer that can beat the best classical computer. Governments are interested in quantum technology because of the many military/defense and overall security implications. For example, quantum computing can render all existing encryption useless and exposed to hacking and infiltration.

This means that all financial transactions and state secrets are potentially at risk with quantum computing. Conversely, quantum computing-enabled encryption will be completely unbreakable. In another example, quantum sensing and imaging may be used to detect the presence of aircraft (even stealth fighters).

Advanced Light Detection and Ranging (LIDAR) systems equipped with quantum imaging processes may identify the presence of aircraft based on minute changes in the environment. Conversely, quantum-equipped planes may similarly foil quantum LIDAR detection systems, protecting themselves by projecting images that simulate a normal ambient environment.

Select Report Findings:

  • Overall global quantum technology market will reach $53.2 billion by 2028
  • Quantum computing will lead the market at $17.6 billion by 2028 and 41.2% CAGR
  • North America will be the biggest regional market for quantum technologies overall
  • China will lead the APAC quantum technology market at $6.31 billion by 2028 with 39.1%CAGR
  • Germany will lead the European quantum technology market at $3.9 billion by 2028 with 30.6%CAGR
  • The global quantum dots market will reach $14.9 billion by 2028, growing a 33.7%CAGR and led by displays
  • The quantum sensing market will reach $1.1 billion globally by 2028, nearly twice the size of the quantum imaging market
  • The quantum magnetometer market will reach $998 million globally by 2028, led by superconducting quantum interference devices

Companies Mentioned

  • 1QB Information Technologies Inc.
  • ABB (Keymile)
  • Adtech Optics Inc.
  • AEGIQ
  • Airbus Group
  • Akela Laser Corporation
  • Alibaba Group Holding Limited
  • Aliro Quantum
  • Alpes Lasers SA
  • Altairnano
  • AmberFlux
  • Amgen Inc.
  • Anhui Qasky Science and Technology
  • Anyon Systems Inc.
  • AOSense Inc.
  • Apple Inc. (InVisage Technologies)
  • AT&T
  • Biogen Inc.
  • Block Engineering
  • BOLTZ.AI
  • Booz Allen Hamilton Inc.
  • Boxcat Inc.
  • BT Group
  • Cambridge Quantum Computing Ltd.
  • Carl Zeiss AG
  • Chinese Academy of Sciences
  • Classiq
  • CogniFrame Inc.
  • ColdQuanta Inc.
  • D-Wave Systems Inc.
  • Elyah
  • Emerson Electric Corporation
  • Entropica Labs
  • Fujitsu Ltd.
  • Gem Systems
  • GeoMetrics Inc.
  • Google Inc.
  • GWR Instruments Inc.
  • Hamamatsu Photonics K.K.
  • Hewlett Packard Enterprise
  • Honeywell International Inc.
  • HP Development Company L.P.
  • HRL Laboratories
  • Huawei Cloud
  • IBM Corporation
  • ID Quantique
  • imec
  • Infineon Technologies
  • Intel Corporation
  • IQM Quantum Computers
  • KEEQuant
  • KETS Quantum Security
  • KPN
  • LG Display Co. Ltd.
  • Lockheed Martin Corporation
  • M-Squared Lasers Limited
  • MagiQ Technologies Inc.
  • Marine Magnetics
  • McAfee LLC
  • MicroSemi Corporation
  • Microsoft Corporation
  • Mirsense
  • Mitsubishi Electric Corp.
  • Muquans
  • Nanoco Group PLC
  • Nanoplus Nanosystems and Technologies GmbH
  • Nanosys Inc.
  • NEC Corporation
  • Next Generation Quantum
  • Nippon Telegraph and Telephone Corporation
  • NN-Labs LLC.
  • Nokia Corporation
  • NuCrypt
  • Ocean NanoTech LLC
  • Oki Electric
  • Oscilloquartz SA
  • OSRAM
  • PQ Solutions Limited (Post-Quantum)
  • Pranalytica Inc.
  • QC Ware Corp.
  • QD Laser Co. Inc.
  • QinetiQ
  • QRCrypto SA
  • QRDLab
  • Quantum Benchmark Labs
  • Quantum Brilliance
  • Quantum Circuits Inc.
  • Quantum Computing Inc.
  • Quantum Machines
  • Quantum Materials Corp.
  • Quantum Thought
  • Qubitekk
  • Qubitrium
  • QuEra Computing
  • Quintessence Labs
  • Qunnect Inc.
  • QuSpin
  • QxBranch LLC
  • Raytheon Company
  • Rigetti Computing
  • Robert Bosch GmbH
  • Samsung Electronics Co. Ltd. (QD Vision Inc.)
  • SeQureNet (Telecom ParisTech)
  • SK Telecom
  • STMicroelectronics
  • Taqbit Labs Pvt Ltd
  • Tencent Quantum Lab
  • Texas Instruments
  • Thorlabs Inc
  • Toshiba Corporation
  • Tristan Technologies
  • Turkcell
  • Twinleaf
  • Universal Quantum Devices
  • Volkswagen AG
  • Wavelength Electronics Inc.
  • ZTE Corporation

For more information about this report visit https://www.researchandmarkets.com/r/r6g4t8

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

AI in Healthcare: Unveiling the Future with a 42.20% CAGR Through 2029

Published

on

ai-in-healthcare:-unveiling-the-future-with-a-42.20%-cagr-through-2029

USA News Group Commentary
VANCOUVER, BC, April 25, 2024 /PRNewswire/ — Across several sectors the use of artificial intelligence (AI) is making a huge impact, with healthcare emerging as possibly receiving the largest boost. According to a new research report from analysts at Mordor Intelligence, the market for artificial intelligence in health care is set to explode at a CAGR of 42.20% through 2029. As the tech sector races to provide the market with solutions, several companies are emerging as leaders in aiding the healthcare sector, including Avant Technologies Inc. (OTC:AVAI), Microsoft Corporation (NASDAQ:MSFT) (NEO:MSFT), Health Catalyst, Inc. (NASDAQ:HCAT), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), and Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX).

Recently, Avant Technologies Inc. (OTC:AVAI) strengthened its AI-powered healthcare offerings by acquiring Wired-4-Health, a company specializing in healthcare technology and data services. This addition supports Avant’s goal to create the first supercomputing network in the country. This network will offer big data and AI software companies a quicker, more potent, and more affordable computing infrastructure.
“Our strategy behind this acquisition was to enable Avant to deliver best-in-class data and system interoperability support services to the healthcare and life sciences sectors powered by AvantAI® and our high-density compute capabilities,” said Tim Lantz, CEO of Avant Technologies. “At the same time, this exciting combination significantly strengthens our financial profile, offers massive commercial growth opportunities in one of Avant’s largest target markets, and bolsters our internal customer support and R&D capabilities.”
The goal of this deal is to bring together Avant Technologies and Wired-4-Health to improve how healthcare data is shared and used. By joining forces, they can use advanced AI and powerful computing to help healthcare and life sciences organizations deal with data and system challenges more easily and effectively.
This partnership improves the way transactions are processed, analyzes health outcomes, and ensures compliance, leading to better performance, more reliable data, and a more affordable, scalable system for customers.
“In the near term, if the healthcare industry expects to succeed in lowering costs while improving quality, the deployment of advanced AI, combined with more powerful, cost- effective compute capabilities will be critical to that success,” said Angela Harris, Avant’s Chief Operating Officer. “The addition of Wired-4-Health will position Avant as a key contributor in helping healthcare organizations solve complex problems at the intersection of cost, quality, compliance and technology.”
Tech giant Microsoft Corporation (NASDAQ:MSFT) (NEO:MSFT) has also been aiding the healthcare sector, most notably with its Azure AI Health Bot, which helps create copilot experiences with healthcare safeguards. Microsoft is enhancing its Azure AI Health Bot services by adding new healthcare-specific safeguards and features, including integration with Microsoft Copilot Studio.
These upgrades allow healthcare organizations to create their own copilot experiences, with pre-built capabilities, templates, and connectors tailored to healthcare needs, supporting protocol-based workflows alongside AI-based answers, and ensuring compliance with industry standards and guidelines. Now the platform is already being put into use by big players, including by German pharma giant Roche.
“By leveraging Azure AI Health Bot to build copilot experiences for doctors, we are developing an intuitive, conversational interface that lets clinicians access and explore Roche’s clinical documentations in a more natural way and to cope with the complexity and flood of information,” said Dr. Georg Isbary of Roche Pharma Germany. “The pilot for this new user experience, powered by generative AI features and compliant with the necessary security standards, has been integrated into our systems and will be further tailored to regional market needs.”
Long-time developer in the AI and machine learning (ML) space for healthcare, Health Catalyst, Inc. (NASDAQ:HCAT) signed a multi-year partnership with SacValley MedShare, one of California’s largest and most established qualified health information organization, earlier this year. As per the deal, Health Catalyst will support SacValley’s important mission through a broad set of technology solutions, including KPI Ninja by Health Catalyst, Healthcare.AI – a Health Catalyst Data Operating System (DOSTM) Platform module, and several other application solutions and Professional Services.
“We are honored to partner with SacValley MedShare on their continued journey to advance healthcare and are confident our technology, combined with our dedicated, skilled team members, will deliver the improved efficiency and support SacValley MedShare needs to achieve its healthcare transformation goals,” said Dan Burton, CEO of Health Catalyst.
By choosing Health Catalyst’s advanced data and analytics services, SacValley will enhance its ability to share and use information. This will lead to better service for those paying for healthcare, by making it easier to share important health details. This helps in delivering top-notch reports and care for patients.
“Transforming data from movable to usable is the alchemy of insights, turning raw potential into the gold of informed decision-making, ultimately forging a path towards health equity and improved outcomes,” said John Helvey, Executive Director of SacValley MedShare. “This is the primary reason SVMS chose Health Catalyst as a transforming partner.”
Another AI player is Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), which is making it easier and cheaper for other biopharma companies to produce important biological materials and organisms by using artificial intelligence (AI). Back in February 2024, Ginkgo announced the acquisition of key assets of Reverie Labs, which has built and used AI/ML tools to accelerate drug discovery. The acquisition of Reverie’s infrastructure and software serves to help train large-scale AI foundation models, while four of Reverie’s key AI team members will also be joining Ginkgo.
Gingko followed this up through a collaboration with UK-based biotech company Prozomix, to build out the production of next generation enzyme plates for active pharmaceutical ingredient (API) manufacturing. The agreement aims to leverage Gingko’s Enzyme Services and industry-leading AI/ML models along with Prozomix’s existing enzyme libraries and deep experience manufacturing enzyme plates.
“API manufacturing is poised to greatly benefit from the latest in enzyme engineering and AI/ML enzyme models,” said Cindy Chang, Senior Director, Business Development at Ginkgo Bioworks. “We are so excited to partner with Prozomix to get enzymes into as many API routes as possible and help partners meet both their COGs savings and sustainability goals.”
Another developer helping to lead the way in AI-powered healthcare is Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), which uses AI to pick out which treatments should be tested in clinical trials, while also letting biopharma companies to use their AI tools to do so also.
Last year, Recursion lined up a $50-million collaboration with AI chipmaking giant Nvidia for AI drug discovery. Then at the beginning of 2024, Recursion presented a demonstration of LOWE (Large Language Model-Orchestrated Workflow Engine), a new software designed to perform complex drug discovery tasks using a natural language interface. The platform is powered by Recursion’s proprietary biological and chemical data, and can orchestrate experiments using Recursion’s automated wet laboratories, unleashing the power of the Recursion Operating System in an easy-to-use tool.
“For the first time, we’ve taught Large Language Models to use many of Recursion’s tools and data in the same way an expert scientist would, but much more simply and in a more scalable way,” said Chris Gibson, Ph.D., Co-founder and CEO of Recursion. “LOWE provides an exciting glimpse into what we believe the future of drug discovery will look like – a first step towards the development of autonomous ‘AI scientists’ for therapeutic discovery.”
Source: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/
CONTACT:USA News [email protected]
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

View original content:https://www.prnewswire.co.uk/news-releases/ai-in-healthcare-unveiling-the-future-with-a-42-20-cagr-through-2029–302127335.html

Continue Reading

Artificial Intelligence

Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

Published

on

oncolytics-biotech-announces-upcoming-presentations-at-the-american-society-of-clinical-oncology-annual-meeting

SAN DIEGO and CALGARY, AB, April 25, 2024 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the acceptance of two abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place from May 31 – June 4, 2024, in Chicago, Illinois. Details on the abstracts and poster presentation are shown below.

Title: Phase 1/2 randomized, open-label, multicenter, Simon two-stage study of pelareorep combined with modified FOLFIRINOX +/- atezolizumab in patients with metastatic pancreatic ductal adenocarcinoma.
Presentation Type: PosterAbstract Number: TPS4203Session Title: Gastrointestinal Cancer – Gastroesophageal, Pancreatic, and HepatobiliarySession Date and Time: June 1, 2024, 1:30 – 4:30 p.m. CTTitle: Pelareorep driven blood TIL expansion in patients with pancreatic, breast and colon cancer.Presentation Type: Online abstractAbstract Number: e14625
Abstracts will be published on the ASCO Annual Meeting website at 5:00 p.m. ET on May 23, 2024.
About Oncolytics Biotech Inc.
Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 studies in metastatic breast cancer and Phase 1 and 2 studies in pancreatic cancer. It acts by inducing anti-cancer immune responses and promotes an inflamed tumor phenotype — turning “cold” tumors “hot” — through innate and adaptive immune responses to treat a variety of cancers.
Pelareorep has demonstrated synergies with multiple approved oncology treatments. Oncolytics is currently conducting and planning combination clinical trials with pelareorep in solid and hematological malignancies as it advances towards registrational studies in metastatic breast cancer and pancreatic cancer, both of which have received Fast Track designation from the FDA. For further information, please visit: www.oncolyticsbiotech.com or follow the company on social media on LinkedIn and on X @oncolytics.
 
Company Contact
Jon Patton
Director of IR & Communication
[email protected]
 
Investor Relations for Oncolytics
Timothy McCarthy
LifeSci Advisors
+1-917-679-9282
[email protected]
 
 

View original content:https://www.prnewswire.co.uk/news-releases/oncolytics-biotech-announces-upcoming-presentations-at-the-american-society-of-clinical-oncology-annual-meeting-302127245.html

Continue Reading

Artificial Intelligence

Internet of Things (IoT) Market to Expand at a Stellar 19.4% CAGR through 2031 | SkyQuest Technology

Published

on

internet-of-things-(iot)-market-to-expand-at-a-stellar-19.4%-cagr-through-2031-|-skyquest-technology

WESTFORD, Mass., April 25, 2024 /PRNewswire/ — SkyQuest projects that the Internet of Things (IoT) Market will attain a value of USD 1572.37 billion by 2031, with a CAGR of 19.4% over the forecast period (2024-2031). Internet of Things (IoT) refers to the network of connected devices over the internet that are embedded with sensors and software. Growing adoption of automation around the world and advancements in connected device technologies are forecasted to be key factors driving the Internet of Things (IoT) market growth in the future.

Download a detailed overview:
https://www.skyquestt.com/report/internet-of-things-market
Browse in-depth TOC on “Internet of Things (IoT) Market”
Pages – 197Tables – 69Figures – 75Internet of Things (IoT) Market Overview:
Report Coverage
Details
Market Revenue in 2023
$ 380.6 billion
Estimated Value by 2031
$1572.37 billion
Growth Rate
Poised to grow at a CAGR of 19.4%
Forecast Period
2024–2031
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Component Type, Application, and Region
Geographies Covered
North America, Europe, Asia Pacific, and the Rest of the world
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Rising demand for connected healthcare and growing use of industrial automation solutions
Key Market Drivers
Advancements in connectivity and connected device technologies
 
 
Hardware is Estimated to Dominate the Global Market Share Owing to High Use of Hardware Components in IoT
Hardware components such as sensors and actuators are highly vital to the proper functioning of any kind of Internet of Things (IoT) device. Growing adoption of IoT devices in different industry verticals for various applications is promoting market growth via this segment. The development of new hardware solutions also helps this segment maintain its dominance.
Smart Agriculture is the Fastest-growing Segment Owing to Rising Adoption of Precision Agriculture Practice
Rising emphasis on improving agricultural yield and sustainability has resulted in the growing adoption of smart agriculture and precision agriculture practices. IoT devices play a crucial role in monitoring and controlling different elements of a smart agriculture setup that is mostly automated using different smart devices thereby contributing to the IoT market growth as well.
Growing Adoption of 5G Technology Allowing North America to Dominate the Global Internet of Things (IoT) Market
Rapid adoption of 5G technology and high use of cloud-based platforms are key factors allowing North America to lead the demand for Internet of Things (IoT) around the world. Surging investments in the research and development of advanced technologies and the presence of key tech giants such as Amazon, Google, IBM, and Microsoft also helps the dominance of this region. Canada and the United States remain the most lucrative markets for Internet of Things (IoT) companies in North America through 2031.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/internet-of-things-market
Internet of Things (IoT) Market Insights:
Drivers
Advancements in connectivity and connected device technologies.Growing demand for Industrial IoT (IIoT) solutions.Increasing number of smart cities and development of smart infrastructure.Restraints
Lack of standardization of IoT devices and technologies.Privacy and data security issues.Interoperability challenges and complex integration scenarios.Prominent Players in Internet of Things (IoT) Market
MicrosoftCisco SystemsIntelSiemens (Germany)AWS (US)Oracle (US)Qualcomm (UK)SAP (Germany)IBM (US)Google (US)View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/internet-of-things-market
Key Questions Answered in Internet of Things (IoT) Market Report
What are the top drivers for Internet of Things (IoT) market going forward?Who are the leading Internet of Things (IoT) market players?Where will demand for Internet of Things (IoT) be high?Which component accounts for a dominant revenue share of the global Internet of Things (IoT) market?This report provides the following insights:
Analysis of key drivers (advancements in connectivity and connected device technologies, growing demand for industrial IoT (IIoT), development of smart infrastructure for smart cities, growing use of smart devices ), restraints (lack of standardization, complexities in integration, concerns regarding security and privacy of data), and opportunities (rising popularity of connected healthcare, increasing adoption of Industry 4.0, rising use of industrial automation), influencing the growth of Internet of Things (IoT) market.Market Penetration: All-inclusive analysis of product portfolio of different market players and status of new product launches.Product Development/Innovation: Elaborate assessment of R&D activities, new product development, and upcoming trends of the Internet of Things (IoT) market.Market Development: Detailed analysis of potential regions where the market has potential to grow.Market Diversification: Comprehensive assessment of new product launches, recent developments, and emerging regional markets.Competitive Landscape: Detailed analysis of growth strategies, revenue analysis, and product innovation by new and established market players.Related Reports:
Global Internet of Things in Retail Market
Global Internet of Things (IoT) in Agriculture Market
Global Internet of Things (IoT) Microcontroller Market
Global IOT In Healthcare Market
Global IOT in Manufacturing Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific. 
Contact:
Mr. Jagraj Singh Skyquest Technology1 Apache Way,Westford,Massachusetts 01886USA (+1) 351-333-4748Email: [email protected] Our Website: https://www.skyquestt.com/

View original content:https://www.prnewswire.co.uk/news-releases/internet-of-things-iot-market-to-expand-at-a-stellar-19-4-cagr-through-2031–skyquest-technology-302127239.html

Continue Reading

Trending